Asklepios BioPharma Launches New Biotech Actus Therapeutics Post author:Sam Post published:December 14, 2017 Post category:BioPharma Asklepios BioPharma is forming a new biotech portfolio company, Actus Therapeutics. Source: BioSpace You Might Also Like Bone Biologics Announces Appointment Of To Company???s Board Of Directors August 3, 2017 2 Fast-Rising Biotech Stocks With No Competition in Sight July 17, 2017 Omeros Pursuing Legal Action Against Short Seller for Report That Caused Stock to Tank This Week June 28, 2017
Omeros Pursuing Legal Action Against Short Seller for Report That Caused Stock to Tank This Week June 28, 2017
